Abstract

India is now seeing in COVID-19-induced Mucormycosis or “black fungus” cases in many regions, despite still grappling with second wave of coronavirus infections. Mucormycosis, also known as black fungus, is a severe but rare fungal infection caused by the mucormycetes, a group of moulds. It usually affects those with health problems or who are taking drugs that limit the body’s ability to combat germs and illness. The resurgence in black fungus infections may be attributed to the use of steroids in the management of COVID infection, as well as the fact that many COVID patients had diabetes as co-morbidity. Despite its occurrence since the beginning of the pandemic, there are still unanswered concerns regarding the origin of this fungal infection. The existing report of black fungus morbidity during the latest COVID-19 crisis in this study is early detection of this potentially life-threatening illness and timely care was critical in lowering mortality rates.